CyLip-20, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ177)

Product Quick View

CyLip-20 is a cyclic lipopeptide antimicrobial peptide that targets Gram-positive and Gram-negative bacteria. CyLip-20 exhibits low hemolytic activity and mild in vivo toxicity. CyLip-20 disrupts the integrity of bacterial outer membrane, inner membrane and cytoplasmic membrane by binding to bacterial lipopolysaccharide (LPS), triggering membrane permeabilization, depolarization and leakage of intracellular contents, and inhibits bacterial biofilm formation. In animal models, CyLip-20 reduces the bacterial load in skin wounds of mice infected with MRSA, promotes wound healing, decreases the levels of inflammatory cytokines and reduces inflammatory cell infiltration. CyLip-20 can be used in research related to MRSA skin wound infections.

Overview
SynonymsCyLip-20; CyLip20; Cysteine-rich lipopeptide 20
SourceSynthetic
SequenceC8-{Dab}-{Dab}-Trp-{d-Tyr}-cyclo(Lys-{Dab}-{Dab}-Trp-{d-Leu}-{d-Leu}-Glu)
Sequence ShorteningC8-{Dab}-{Dab}-W-{d-Tyr}-cyclo(K-{Dab}-{Dab}-W-{d-Leu}-{d-Leu}-E)
ActivityGram-positive bacteria; Gram-negative bacteria; Fungi; Virus; Cancer cells; Biofilm
Physical StatePowder
Purity>98%
StorageThe power can be stored at 4°C for 2 years or at -20°C for 3 years.

For Research Use Only.

Related products
Online Inquiry
Name:
Phone:
*E-mail Address:
*Service & Products Interested:
Project Description:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.